- Filed
- Aug 13, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Aug 9, 2024 | 70.56M sh |
| Short Term Investments | Q2 2024 · Jun 30, 2024 | $204.42M |
| Short Term Investments | Q2 2024 · Dec 31, 2023 | $217.15M |
| Current Liabilities | Q2 2024 · Jun 30, 2024 | $20.86M |
| Current Liabilities | Q2 2024 · Dec 31, 2023 | $23.33M |
| Total Liabilities | Q2 2024 · Jun 30, 2024 | $100.9M |
| Total Liabilities | Q2 2024 · Dec 31, 2023 | $105.6M |
| Current Assets | Q2 2024 · Jun 30, 2024 | $331.8M |
| Current Assets | Q2 2024 · Dec 31, 2023 | $253.07M |
| Total Assets | Q2 2024 · Jun 30, 2024 | $554.09M |
| Total Assets | Q2 2024 · Dec 31, 2023 | $378.89M |
| Cash And Equivalents | Q2 2024 · Dec 31, 2023 | $31.04M |
| Cash And Equivalents | Q2 2024 · Jun 30, 2023 | $29.12M |
| Shares Diluted | Q2 2024 · Jun 30, 2023 | 48.97M sh |
| Shares Diluted | Q2 2024 · Jun 30, 2023 | 48.95M sh |
| Capex | Q2 2024 · Jun 30, 2023 | $15.15M |
| Operating Cash Flow | Q2 2024 · Jun 30, 2023 | −$42.53M |
| Stockholders Equity | Q2 2024 · Jun 30, 2023 | $317.98M |
| Stockholders Equity | Q2 2024 · Mar 31, 2023 | $346.65M |
| Stockholders Equity | Q2 2024 · Dec 31, 2022 | $372.21M |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | −$0.68 |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | −$1.31 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | −$0.68 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | −$1.31 |
| Sga Expense | Q2 2024 · Jun 30, 2023 | $11.74M |
| Sga Expense | Q2 2024 · Jun 30, 2023 | $19.91M |
| Rd Expense | Q2 2024 · Jun 30, 2023 | $25.12M |
| Rd Expense | Q2 2024 · Jun 30, 2023 | $51.26M |
| Net Income | Q2 2024 · Jun 30, 2023 | −$33.29M |
| Net Income | Q2 2024 · Jun 30, 2023 | −$64.1M |
| Net Income | Q2 2024 · Mar 31, 2023 | −$30.82M |
| Operating Income | Q2 2024 · Jun 30, 2023 | −$36.86M |
| Operating Income | Q2 2024 · Jun 30, 2023 | −$71.17M |